sandra-Challma

Alzheimer’s disease has had extensive research over the years. Now, you’ll find a series of ways to detect the disease and its impact on humans without having to wait till the last moment. Research and innovation have made it easier for medical practitioners to assess a patient’s situation and provide them with appropriate diagnoses. Therefore, new and upcoming methods are now practiced across the world to ensure effectiveness and early detection.

Patients diagnosed with dementia are likely to develop Alzheimer’s disease. There are a number of factors that play into the existence of the illness. Yet, the pattern that follows in every patient diagnosed with the disease is more or less the same. Alzheimer’s disease is a progressive illness that begins with mild memory loss leading to confusion and inability to carry on with a conversation.

According to NIH, more than 6 million Americans are living with Alzheimer’s disease. Recent studies suggest that somewhere between 50-80% of patients aren’t diagnosed with this ailment because of inefficient procedures that are related to the traditional diagnosis methods. In the past two years screening for Alzheimer’s was made even trickier due to the COVID-19 pandemic and the fact that a huge percentage of people with symptoms aren’t able to arrange an appointment. 

Alzheimer’s disease is one of the most prevalent ailments of the 21st century. However, studies suggest that millions of Alzheimer’s cases remain undetected due to the inefficiency of the invasive diagnosis as well as the expensive procedures that accompany the traditional methods. 

If you are specializing in becoming a neurologist, you are likely to encounter people who suffer from Alzheimer’s disease. With more than 6 million US citizens affected, it is one of the most prevalent ailments of the 21st century. Your role as a doctor is to suggest relevant treatment and measures which can slow down or completely prevent the progression of this disease. 

When it comes to Alzheimer’s diagnosis, getting an inexpensive and early diagnosis is one of the more challenging things to do in the medical field. This can leave both patients and hospitals feeling like they’re fighting an uphill battle against this disease. That’s why every hospital can benefit from this new and innovative Alzheimer’s diagnostic test. 

Stevens Institute of Technology is one of the oldest technology universities in the United States. It is also amongst the first universities in the nation to enter the field of mechanical engineering. Since 1870, Stevens Institute of Technology’s research and development department has been significantly influential in terms of innovation in several fields. 

The outlook for patients with Alzheimer’s disease relies on receiving an early and correct diagnosis, it is key for starting the appropriate treatment. For many families the current methods of diagnosis for Alzheimer’s disease available today are too expensive and unattainable, considering the time-consuming diagnostic procedures. In addition, current assessment tests are not always able to detect the disease at its earliest stages. 

Alzheimer’s disease is a very real condition that affects thousands of people across the world. For this reason, it is essential that doctors and scientists work together in order to find innovative ways in which to diagnose and treat this disease. Although there is no cure for this disease, doctors will be able to slow its progression and delay symptoms through various treatments.